| 臺大學術典藏 |
2018-09-10T15:18:57Z |
Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition
|
Su, T.-H. and Shiau, C.-W. and Jao, P. and Liu, C.-H. and Liu, C.-J. and Tai, W.-T. and Jeng, Y.-M. and Yang, H.-C. and Tseng, T.-C. and Huang, H.-P. and Cheng, H.-R. and Chen, P.-J. and Chen, K.-F. and Kao, J.-H. and Chen, D.-S.; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; Su, Tung-Hung;Shiau, Chung-Wai;Jao, Ping;Liu, Chen-Hua;Liu, Chun-Jen;Tai, Wei-Tien;Jeng, Yung-Ming;Yang, Hung-Chih;Tseng, Tai-Chung;Huang, Hsiang-Po;Cheng, Huei-Ru;Chen, Pei-Jer;Chen, Kuen-Feng;Kao, Jia-Horng;Chen, Ding-Shinn; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; 陳定信;劉振驊;高嘉宏;鄭永銘;楊宏志;蘇東弘;陳昆鋒;劉俊人;陳培哲; HUNG-CHIH YANG; Su, Tung-Hung; HSIANG-PO HUANG; Shiau, Chung-Wai; Jao, Ping; CHUN-JEN LIU; Liu, Chen-Hua; PEI-JER CHEN; YUNG-MING JENG; Liu, Chun-Jen; CHEN-HUA LIU; Tai, Wei-Tien; DING-SHINN CHEN; Cheng, Wern-Cherng; Jeng, Yung-Ming; Yang, Hung-Chih; TUNG-HUNG SU; JIA-HORNG KAO; Tseng, Tai-Chung; Huang, Hsiang-Po; Cheng, Huei-Ru; Chen, Pei-Jer; Chen, Kuen-Feng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen, K.-F.;Chen, H.-L.;Shiau, C.-W.;Liu, C.-Y.;Chu, P.-Y.;Tai, W.-T.;Ichikawa, K.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:34:22Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen K.-F.; Chen H.-L.; Shiau C.-W.; Liu C.-Y.; Chu P.-Y.; Tai W.-T.; Ichikawa K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:53:51Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen K.-F.; Chen H.-L.; Shiau C.-W.; Liu C.-Y.; Chu P.-Y.; Tai W.-T.; Ichikawa K.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2012 |
Sorafenib and its derivatives induce apoptosis and autophagy in canine mammary tumor cells
|
Lee, Yi-Yen; Chen, Kuen-Feng; Chou, Chung-Hsi; Lin, Chen-Si; CHUNG-HSI CHOU |
| 臺大學術典藏 |
2021-09-01T01:54:28Z |
Sorafenib benefits Asian patients with advanced HCC
|
ANN-LII CHENG |
| 中國醫藥大學 |
2014-09-07 |
Sorafenib Combined with Transarterial Chemoembolization or Radiation Therapy Versus Sorafenib Alone For Advanced Stage Hepatocellular Carcinoma –A Daily Practice Analysis
|
莊伯恒(Po-Heng Chuang);鄭隆賓(Long-Bin Jeng);賴學洲(Hsueh-Chou Lai);彭成元(Cheng-Yuan Peng);高榮達(Jung-Ta Kao);鄭庚申(Ken-Sheng Cheng) |
| 臺大學術典藏 |
2018-09-10T08:41:21Z |
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
|
Chen, K.-F.;Tai, W.-T.;Huang, J.-W.;Hsu, C.-Y.;Chen, W.-L.;Cheng, A.-L.;Chen, P.-J.;Shiau, C.-W.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:34:40Z |
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
|
Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; Cheng A.-L.; PEI-JER CHEN; Shiau C.-W. |
| 臺大學術典藏 |
2021-09-01T01:54:10Z |
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
|
Chen K.-F.; Tai W.-T.; Huang J.-W.; Hsu C.-Y.; Chen W.-L.; ANN-LII CHENG; Chen P.-J.; Shiau C.-W. |
| 臺大學術典藏 |
2021-05-18T08:20:17Z |
Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3
|
CHAO-YUAN HUANG; Lin C.-S.; Tai W.-T.; Hsieh C.-Y.; Shiau C.-W.; Cheng A.-L.; Chen K.-F. |
| 臺大學術典藏 |
2021-09-01T01:53:47Z |
Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3
|
Huang C.-Y.; Lin C.-S.; Tai W.-T.; Hsieh C.-Y.; Shiau C.-W.; ANN-LII CHENG; Chen K.-F. |
| 臺大學術典藏 |
2021-10-14T03:48:58Z |
Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3
|
CHAO-YUAN HUANG; Lin, Chen-Si; Tai, Wei-Tien; Hsieh, Chi-Ying; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Kuen-Feng |
| 臺大學術典藏 |
2022-05-05T03:09:24Z |
Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3
|
CHAO YUAN HUANG; Lin C.-S.; Tai W.-T.; Hsieh C.-Y.; Shiau C.-W.; Cheng A.-L.; Chen K.-F. |
| 中山醫學大學 |
2012 |
Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
|
Teng, Chieh-Lin; Hwan, Wen-Li; Chen, Yi-Ju; Chang, Kuang-Hsi; Cheng, Shao-Bin |
| 中山醫學大學 |
2012-02 |
Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
|
CL, Teng; WL, Hwang; YJ, Chen; KH, Chang; SB, Cheng |
| 臺大學術典藏 |
2022-08-19T00:21:04Z |
Sorafenib for the treatment of hepatocellular carcinoma across geographic regions
|
CHIUN HSU; Shen Y.-C.; Cheng A.L. |
| 臺大學術典藏 |
2009 |
Sorafenib for the treatment of hepatocellular carcinoma across geographic regions
|
Cheng A.L.; Shen Y.-C.; Chiun Hsu |
| 臺大學術典藏 |
2021-09-01T01:54:19Z |
Sorafenib for the treatment of hepatocellular carcinoma across geographic regions
|
Hsu C.; Shen Y.-C.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-03-09T05:18:38Z |
Sorafenib for the treatment of hepatocellular carcinoma across geographic regions
|
Hsu C.; Ying-Chun Shen; Cheng A.L. |
| 中國文化大學 |
2013-02 |
Sorafenib induces autophagy and suppresses activation of human macrophage
|
Lin, JC (Lin, Jiunn-Chang); Liu, CL (Liu, Chien-Liang); Lee, JJ (Lee, Jie-Jen); Liu, TP (Liu, Tsan-Pai); Ko, WC (Ko, Wen-Chin); Huang, YC (Huang, Yu-Chuen); Wu, CH (Wu, Chih-Hsiung); Chen, YJ (Chen, Yu-Jen) |
| 中國文化大學 |
2013-05 |
Sorafenib induces autophagy and suppresses activation of human macrophage (vol 15, pg 333, 2013)
|
Lin, JC (Lin, Jiunn-Chang); Liu, CL (Liu, Chien-Liang); Lee, JJ (Lee, Jie-Jen); Liu, TP (Liu, Tsan-Pai); Ko, WC (Ko, Wen-Chin); Huang, YC (Huang, Yu-Chuen); Wu, CH (Wu, Chih-Hsiung); Chen, YJ (Chen, Yu-Jen) |
| 中國文化大學 |
2013-03-27 |
Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts
|
Lin, JC (Lin, Jiunn-Chang); Huang, WP (Huang, Wei-Pang); Liu, CL (Liu, Chien-Liang); Lee, JJ (Lee, Jie-Jen); Liu, TP (Liu, Tsang-Pai); Ko, WC (Ko, Wen-Chin); Huang, YC (Huang, Yu-Chuen); Hsu, ML (Hsu, Ming-Ling); Wu, CH (Wu, Chih-Hsiung); Chen, YJ (Chen, Yu-Jen) |
| 臺北醫學大學 |
2013 |
Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts
|
Lin;J, C.;Huang, W. P.;Liu, C. L.;Lee, J. J.;Wu, C. H.;Chen, Y. J. |
| 臺北醫學大學 |
2013 |
Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts
|
Lin;J.C.;W.P.Huang;C.L.Liu;J.J.Lee;C.H.Wu;Y.J.Chen |
| 臺大學術典藏 |
2018-09-10T09:44:21Z |
Sorafenib induces autophagy in human myeloid dendritic cells and prolongs survival of skin allografts
|
WEI-PANG HUANG;Chen, Y.-J.;Wu, C.-H.;Hsu, M.-L.;Huang, Y.-C.;Ko, W.-C.;Liu, T.-P.;Lee, J.-J.;Liu, C.-L.;Huang, W.-P.;Lin, J.-C.; Lin, J.-C.; Huang, W.-P.; Liu, C.-L.; Lee, J.-J.; Liu, T.-P.; Ko, W.-C.; Huang, Y.-C.; Hsu, M.-L.; Wu, C.-H.; Chen, Y.-J.; WEI-PANG HUANG |
| 國立臺灣大學 |
2008 |
Sorafenib Is Effective in Patients from the Asia-Pacific Region with Hepatocellular Carcinoma (Hcc) Subgroup Analysis of Effect of Macroscopic Vascular Invasion, Extrahepatic Spread, and Ecog Performance Status on Outcome
|
曹朝榮; 鄭安理; TSAO, CHAO-JUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2
|
陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2009 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Signal Transducers and Activators of Transcription 3
|
陳昆鋒; 戴瑋恬; 陳培哲; 鄭安理; CHEN, KUEN-FENG; TAI, WEI-TIEN; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2010 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Stat3
|
陳昆鋒; 黃祥博; 林育靖; 蕭崇瑋; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HUANG, HSIANG-PO; LIN, YU-CHIN; SHIAU, CHUNG-WAI; CHEN, PEI-JER; CHENG, ANN-LII |
| 臺大學術典藏 |
2018-09-10T08:04:03Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2021-06-03T06:50:19Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; Liu T.-H.; HSIANG-PO HUANG; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-07-03T03:34:40Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:12Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-03-19T01:54:21Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; TSUNG-HAO LIU; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; Cheng A.-L. |
| 義守大學 |
2016-11 |
Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model
|
John Chun-Hao Chen;Hui-Yen Chuang;Fei-Ting Hsu;Yi-Chen Chen;Yi-Chun Chien;Jeng-Jong Hwang |
| 臺北醫學大學 |
2014 |
Sorafenib Prolongs Skin Allograft Survival Through Upregulation of Treg and Autophagy-Related Mechanism In Vivo
|
Lin, Jiunn-Chang;Liu, Chien-Liang;Lee, Jie-Jen;Liu, Tsang-Pai;Ko, Wen-Ching;Wu, Chih-Hsiung;Chen, Yu-Jen |
| 國立臺灣大學 |
2014 |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen, Mei-Ling; Yan, Bo-Shiun; Lu, Wan-Chih; Chen, Mei-Huei; Yu, Sung-Liang; Yang, Pan-Chyr Cheng, Ann-Lii; 俞松良; 楊泮池; 陳美齡; 鄭安理; 顏伯勳 |
| 臺大學術典藏 |
2018-09-10T14:50:19Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen, M.-L. and Yan, B.-S. and Lu, W.-C. and Chen, M.-H. and Yu, S.-L. and Yang, P.-C. and Cheng, A.-L.; Chen, Mei-Ling;Yan, Bo-Shiun;Lu, Wan-Chih;Chen, Mei-Huei;Yu, Sung-Liang;Yang, Pan-Chyr
Cheng, Ann-Lii; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; Hsu, F.M.; SUNG-LIANG YU; Chen, Mei-Ling; Chen, Mei-Ling; Yan, Bo-Shiun; BO-SHIUN YAN; Hsu, F.M.; ANN-LII CHENG; Lu, Wan-Chih; Chen, Mei-Huei; Chen, Mei-Huei; Yu, Sung-Liang; Yang, Pan-Chyr
Cheng, Ann-Lii; 楊泮池 |
| 臺大學術典藏 |
2020-01-21T01:20:42Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Cheng A.-L.; Yang P.-C.; Yu S.-L.; Chen M.-H.; Lu W.-C.; BO-SHIUN YAN; Chen M.-L. |
| 臺大學術典藏 |
2020-12-02T02:33:42Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen M.-L.;Yan B.-S.;Lu W.-C.;Chen M.-H.;Yu S.-L.;PAN-CHYR YANG;Cheng A.-L.; Chen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; PAN-CHYR YANG; Cheng A.-L. |
| 臺大學術典藏 |
2021-08-31T06:42:24Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; Yang P.-C.; ANN-LII CHENG |
| 國立成功大學 |
2022-11 |
Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8(+) T cell activation to eradicate hepatocellular carcinoma
|
Cheng;-Chia, Chun;Ho;Ai-Sheng;Peng;Cheng-Liang;Chang;Jungshan;Sie;Zong-Lin;Wang;Chih-Liang;Chen;Yi-Li;Chen;Cheng-Yi |
| 國立成功大學 |
2022 |
Sorafenib suppresses radioresistance and synergizes radiotherapy-mediated CD8+ T cell activation to eradicate hepatocellular carcinoma
|
Cheng, Cheng C.-C.;Ho, A.-S.;Peng, C.-L.;Chang, J.;Sie, Z.-L.;Wang, C.-L.;Chen, Y.-L.;Chen, Chen C.-Y. |
| 中山醫學大學 |
2019-11 |
Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status
|
Lee, Shou-Wu;Lee, Teng-Yu;Peng, Yen-Chun;Yang, Sheng-Shun;Yeh, Hong-Zen;Chang, Chi-Sen |
| 亞洲大學 |
2019-07 |
Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study
|
郭集慶;Kok, Victor C.;陳玉菁;CHEN, YU-CHING;陳洋源;Chen, Yang-Yuan;蘇裕傑;Su, Yu-Chieh;古明昌;Ku, Ming-Chang;郭榮宗;Kuo, Jung-Tsung;吉田剛;Yoshida, Go J. |
| 國立成功大學 |
2009-11-27 |
Sorafenib 抑制Erk/Pin-1訊息傳導路徑降低 Myeloid cell leukemia-1表現促使乳癌化療敏感性
|
Ding, Qingqing;Huo, Longfei;Yang, Jer-Yen;Xia, Weiya;魏永昆;Liao, Yong;張君如;李東芳;顏家瑞;Cheng, Rita Yun-Ju;許榮茂;郭旭萍;洪明奇 |
| 國立臺灣大學 |
2016 |
Sorafenib-fortified zein-chondroitin sulphate biopolymer nanoparticles as a novel therapeutic system in gastric cancer treatment
|
Cheng, Hao-Tsai; Hsieh, Sen-Yung; Chen, Tsung-Hsing; Hung, Pei-Fang; Pan, Szu-Hua; 潘思樺 |
| 臺大學術典藏 |
2021-06-04T03:32:12Z |
Sorafenib-fortified zein-chondroitin sulphate biopolymer nanoparticles as a novel therapeutic system in gastric cancer treatment
|
Cheng H.-T.; Hsieh S.-Y.; Chen T.-H.; Hung P.-F.; SZU-HUA PAN |
| 國立成功大學 |
2021-11~2021-12 |
Sorafenib-Induced Eruptive Melanocytic Lesions
|
Chen;Hui-Chun;Chao;Sheau-Chiou |
